3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Interventions
pembrolizumab
4
Cisplatin
3
Carboplatin
3
budigalimab
2
Pemetrexed
2
Paclitaxel
2
Immunotherapy
2
Etoposide
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
venetoclax
1
trametinib
1
spartalizumab
1
sargramostim
1
rovalpituzumab tesirine
1
ribociclib
1
poly ICLC
1
fludarabine
1
enzalutamide
1
entinostat
1
belinostat
1
UV1 vaccine
1
Tomography, Optical Coherence
1
Thrombopoietin
1
Sunitinib
1
Sirolimus
1
Quality of Life
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
UV1 vaccine
×
Other solid neoplasm
×
Clear all
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled